On the other hand, an ErbB4 antibody that blocks ErbB4 and NRG1 interaction appeared to have a stimulatory effect in some of the ovarian cancer cell lines tested, suggesting a possible role for ErbB4 in growth inhibition in these cells (Gilmour et al, 2001). This evidence concerns the gene ERBB4 and ovarian carcinoma.